清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

The impact of the new TNM classification on survival of patients in stage III non-small cell lung cancer

作者
Martina Vrankar,Karmen Stanič
出处
期刊:Annals of Oncology [Elsevier BV]
卷期号:29: viii489-viii489
标识
DOI:10.1093/annonc/mdy291.003
摘要

Background: In the new 8th TNM classification, stage III non-small cell lung cancer (NSCLC) is divided into three subgroups. Stage IIIA includes T4 N0 M0 and T3/4 N1 M0 tumours as well as T1/T2 N2 M0 tumours. Stage IIIB tumours are either T3/T4 N2 M0 or T1/T2 N3 M0. Stage IIIC involves T3/T4 N3 M0 tumours. Beside new IIIC stage, the greatest change is reclassification of T category based on dimension. Tumours larger than 7 cm that were previously T3 are now staged T4. The anatomic extent of disease is the base of the TNM classification with impact on survival. The aim of this analysis was to determine applicability of the new 8th TNM edition on survival of stage III NSCLC treated with combined radiochemotherapy between 2005 and 2010 in our institution. Methods: A total of 101 patient with stage III NSCLC treated between September 2005 and November 2010 with induction chemotherapy and radiochemotherapy were included in long term survival analysis of TNM restaging. Results of survival are presented for the 7th and 8th edition in view of the revised T stage. Results: After a median follow up of 117.5 months, median overall survival (mOS) of stage IIIA patients according to the 7th TNM classification was significantly longer than those of stage IIIB patients (30.8 months and 19.0 months, p = 0.005). Redefinition of the stages according to the new 8th TNM classification showed similar mOS for patients in stage IIIA and stage IIIB (21.6 months and 24.9 months), but much shorter mOS for stage IIIC patients with 6.6 months (p = 0.885). Of 101 patient 13 were up-graded from T3 to T4 according to new TNM classification. In the 7th TNM classification T3N2 was in stage IIIA and T4N2 in stage IIIB, while in 8th TNM classification both are in stage IIIB. According to 7th TNM classification, mOS of patients in stage T3N2 was significantly longer with 60.0 months than in stage T4N2 with 19.2 months (p = 0.004). After the revision there is no difference, mOS of patients with T3N2 was 28.4 months and with T4N2 was 31.4 months (p = 0.478). Conclusions: The statistical difference in survival between subgroups of stage III shown in the old TNM classification did not appear in the new classification. Other factors could affect prognosis that are patient, tumour and treatment related. Legal entity responsible for the study: Martina Vrankar. Funding: Has not received any funding. Disclosure: All authors have declared no conflicts of interest.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI6.4的应助被6666采纳,获得10
2秒前
懦弱的绿蝶完成签到,获得积分10
4秒前
奋斗的白开水完成签到,获得积分10
5秒前
陵墨完成签到,获得积分10
8秒前
notsoeasy完成签到,获得积分10
10秒前
整齐的开山完成签到,获得积分10
11秒前
516165165完成签到,获得积分10
11秒前
11秒前
小巧的绮完成签到,获得积分10
13秒前
越过山丘完成签到,获得积分10
13秒前
null的应助被369ninja采纳,获得10
14秒前
求助完成签到,获得积分10
15秒前
幸福的盼芙完成签到,获得积分10
15秒前
独特的又菱完成签到,获得积分10
16秒前
ryyy1208完成签到,获得积分10
16秒前
ybcy完成签到,获得积分10
17秒前
wrxaa完成签到,获得积分10
18秒前
20秒前
大力的映天完成签到,获得积分10
21秒前
潘润朗完成签到,获得积分10
21秒前
qimoqi完成签到,获得积分10
22秒前
ln完成签到,获得积分10
22秒前
莫忘初心完成签到,获得积分10
22秒前
23秒前
23秒前
搜集达人的应助被TingtingGZ采纳,获得10
25秒前
友好语风完成签到,获得积分10
27秒前
NiaoJiang完成签到,获得积分10
27秒前
Wtony完成签到 ,获得积分0
27秒前
INC完成签到,获得积分10
29秒前
迷人的危险最值钱完成签到,获得积分10
31秒前
美好的初翠完成签到,获得积分10
32秒前
July完成签到,获得积分10
32秒前
kkdg完成签到,获得积分10
34秒前
邓大瓜完成签到,获得积分10
34秒前
脑洞疼的应助被369ninja采纳,获得10
34秒前
MaidLingYan完成签到,获得积分10
38秒前
38秒前
38秒前
DrPika完成签到,获得积分10
38秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173194
求助须知:如何正确求助?哪些是违规求助? 9565558
关于积分的说明 21780496
捐赠科研通 7767299
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555697
邀请新用户注册赠送积分活动 2476688